K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Kaken Pharmaceutical Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kaken Pharmaceutical Co Ltd
Net Change in Cash Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
Net Change in Cash
-ÂĄ8.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Change in Cash
ÂĄ487.9B
CAGR 3-Years
96%
CAGR 5-Years
6%
CAGR 10-Years
7%
Daiichi Sankyo Co Ltd
TSE:4568
Net Change in Cash
ÂĄ285.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
51%
Otsuka Holdings Co Ltd
TSE:4578
Net Change in Cash
-ÂĄ12.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Change in Cash
ÂĄ236.5B
CAGR 3-Years
189%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Change in Cash
-ÂĄ258.6B
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A

See Also

What is Kaken Pharmaceutical Co Ltd's Net Change in Cash?
Net Change in Cash
-8.9B JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's Net Change in Cash amounts to -8.9B JPY.

What is Kaken Pharmaceutical Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
-2 355%

Over the last year, the Net Change in Cash growth was -2 355%.

Back to Top